ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,293,548 | -8.5% | 158,200 | +3.6% | 0.25% | +112.6% |
| Q2 2023 | $4,693,998 | +17.8% | 152,700 | +38.1% | 0.12% | +14.4% |
| Q1 2023 | $3,984,918 | +66326.4% | 110,600 | -27.1% | 0.10% | -42.9% |
| Q4 2022 | $5,999 | -99.9% | 151,800 | -10.8% | 0.18% | -18.8% |
| Q3 2022 | $6,839,000 | +16.8% | 170,200 | +22.2% | 0.22% | +33.3% |
| Q2 2022 | $5,856,000 | +3.3% | 139,300 | -2.1% | 0.17% | +46.1% |
| Q4 2021 | $5,671,000 | -1.1% | 142,300 | -10.3% | 0.12% | -2.5% |
| Q3 2021 | $5,732,000 | +7.5% | 158,600 | +21.9% | 0.12% | +8.3% |
| Q2 2021 | $5,333,000 | +21.9% | 130,100 | +29.7% | 0.11% | +13.5% |
| Q1 2021 | $4,375,000 | -25.2% | 100,300 | -14.1% | 0.10% | -25.6% |
| Q4 2020 | $5,846,000 | – | 116,800 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |